Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study on Using Radiofrequency to Treat Moderate to Severe Acne [NA]
A clinical trial is evaluating a radiofrequency treatment for moderate to severe acne vulgaris. The study is currently active but not recrui…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients
This non-interventional translational study in patients with mild, moderate, and severe acne is not yet recruiting, sponsored by the Nationa…
-
EMA approval · 2026-02-10EMA Authorised: Winlevi (clascoterone) — Cassiopea S.p.A.
The European Medicines Agency has authorized Winlevi (clascoterone) by Cassiopea S.p.A. for acne vulgaris.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Lipidome and Microbiome Profile of Acne [Phase 1, Phase 2]
The University of California, Davis is conducting a Phase 1/Phase 2 study to characterize the lipidome and microbiome of acne vulgaris to un…
-
FDA approval · 2026-02-10FDA Approved: TRETINOIN — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals, Inc.'s original application for a generic tretinoin product (ANDA 217833). This marks the first generic versio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin from Amneal Pharmaceuticals NY LLC, enabling a generic version of the acne medicati…
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for isotretinoin from Mayne Pharma.
-
FDA approval · 2026-02-09FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA LD (isotretinoin) submitted by Sun Pharmaceutical Industries, expanding/altering th…
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for isotretinoin from Upsher-Smith Laboratories, LLC, to modify/expand the existing labeling of …
-
FDA approval · 2026-02-09FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Claravis (isotretinoin) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for isotretinoin (ANDA213571).
-
FDA approval · 2026-02-09FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, Inc., updating the labeling through …
-
FDA label_change · 2026-02-09FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals, resulting in a label/labeling change fo…
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for isotretinoin from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for isotretinoin from Actavis Pharma, Inc., authorizing changes to the approved product.
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin submitted by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2026-02-09FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Claravis (isotretinoin) filed by Teva Pharmaceuticals USA, Inc., resulting in an approved mo…
-
FDA approval · 2026-02-09FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for ZENATANE (isotretinoin) submitted by BluePoint Laboratories, approving continued approval of…
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for isotretinoin submitted by Zydus Pharmaceuticals USA Inc. (ANDA 211568).
-
FDA approval · 2026-02-09FDA Approved: ISOTRETINOIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for isotretinoin by Aurobindo Pharma Limited. This represents a routine approval for a generic isotr…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne [Phase 1]
A Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TVB-3567 in healthy participants with or wit…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris [Phase 4]
A Phase 4 clinical trial comparing topical metronidazole 2% gel with clindamycin 1% gel for moderate acne vulgaris is listed as not yet recr…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Comparison of Efficacy of Azithromycin Alone vs Combination of Azithromycin and Probiotics in Management of Mild to Moderate Acne Vulgaris [Phase 4]
Phase 4 clinical trial comparing azithromycin alone to azithromycin plus probiotics for mild to moderate acne vulgaris; the study is current…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris [Phase 4]
Completed Phase 4 clinical trial comparing oral metformin with doxycycline for acne vulgaris.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients [Phase 4]
Phase 4 clinical trial update for clascoterone 1% cream in acne vulgaris to assess changes in sebaceous glands and sebum. The study is curre…